These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20965230)

  • 1. The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth.
    Roell D; Baniahmad A
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):1-8. PubMed ID: 20965230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
    Papaioannou M; Schleich S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
    Invest New Drugs; 2010 Dec; 28(6):729-43. PubMed ID: 19771394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-guided isolation of an antiandrogenic compound of Pygeum africanum.
    Schleich S; Papaioannou M; Baniahmad A; Matusch R
    Planta Med; 2006 May; 72(6):547-51. PubMed ID: 16773539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth.
    Papaioannou M; Schleich S; Prade I; Degen S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
    J Cell Mol Med; 2009 Aug; 13(8B):2210-2223. PubMed ID: 18627423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purple rice extract inhibits testosterone-induced rat prostatic hyperplasia and growth of human prostate cancer cell line by reduction of androgen receptor activation.
    Kiriya C; Yeewa R; Khanaree C; Chewonarin T
    J Food Biochem; 2019 Sep; 43(9):e12987. PubMed ID: 31489669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational and functional analysis of the androgen receptor antagonist atraric acid and its derivatives.
    Papaioannou M; Söderholm AA; Hong W; Dai Y; Roediger J; Roell D; Thiele M; Nyrönen TH; Baniahmad A
    Anticancer Agents Med Chem; 2013 Jun; 13(5):801-10. PubMed ID: 23194423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activity.
    Schleich S; Papaioannou M; Baniahmad A; Matusch R
    Planta Med; 2006 Jul; 72(9):807-13. PubMed ID: 16783690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of
    Chai X; Sun H; Zhou W; Chen C; Shan L; Yang Y; He J; Pang J; Yang L; Wang X; Cui S; Fu Y; Xu X; Xu L; Yao X; Li D; Hou T
    J Med Chem; 2022 Feb; 65(3):2507-2521. PubMed ID: 35077161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health.
    Thompson RQ; Katz D; Sheehan B
    J Pharm Biomed Anal; 2019 Jan; 163():162-169. PubMed ID: 30316061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor antagonists for prostate cancer therapy.
    Helsen C; Van den Broeck T; Voet A; Prekovic S; Van Poppel H; Joniau S; Claessens F
    Endocr Relat Cancer; 2014 Aug; 21(4):T105-18. PubMed ID: 24639562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.
    Shenouda NS; Sakla MS; Newton LG; Besch-Williford C; Greenberg NM; MacDonald RS; Lubahn DB
    Endocrine; 2007 Feb; 31(1):72-81. PubMed ID: 17709901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway.
    Divakar S; Saravanan K; Karthikeyan P; Elancheran R; Kabilan S; Balasubramanian KK; Devi R; Kotoky J; Ramanathan M
    Chem Biol Interact; 2017 Sep; 275():22-34. PubMed ID: 28757136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative approaches to prevent androgen action in prostate cancer: are we there yet?
    Elbanna M; Heemers HV
    Discov Med; 2014 May; 17(95):267-74. PubMed ID: 24882718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in dietary androgen receptor inhibitors.
    Ren L; Zhang T; Zhang J
    Med Res Rev; 2024 Jul; 44(4):1446-1500. PubMed ID: 38279967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling androgen receptor flexibility: a binding mode hypothesis of CYP17 inhibitors/antiandrogens for prostate cancer therapy.
    Gianti E; Zauhar RJ
    J Chem Inf Model; 2012 Oct; 52(10):2670-83. PubMed ID: 22924551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
    Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
    Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth.
    Fousteris MA; Schubert U; Roell D; Roediger J; Bailis N; Nikolaropoulos SS; Baniahmad A; Giannis A
    Bioorg Med Chem; 2010 Oct; 18(19):6960-9. PubMed ID: 20826091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists.
    Yamamoto S; Kobayashi H; Kaku T; Aikawa K; Hara T; Yamaoka M; Kanzaki N; Hasuoka A; Baba A; Ito M
    Bioorg Med Chem; 2013 Jan; 21(1):70-83. PubMed ID: 23199477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the effects and molecular mechanisms of dimethylcurcumin (ASC-J9) on androgen receptor-related diseases.
    Hu H; Zhou H; Xu D
    Chem Biol Drug Des; 2021 Apr; 97(4):821-835. PubMed ID: 33277796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.